Fmoc-PEG6-VCP-Eribulin
Fmoc-PEG6-VCP-Eribulin is a derivative of Eribulin. Eribulin (E7389) is an anticancer agent targeting microtubules (microtubule) and is utilized in the study of metastatic breast cancer. It inhibits cancer cell proliferation by binding to tubulin and microtubules.
Product Specifications
CAS Number
2841688-52-4
Smiles
C=C1C[C@@]2 (CC[C@@]34O[C@]5 ([C@@] (C3) (O[C@]6 ([C@@] (O4) ([C@@]7 ([C@@] (O[C@@]56[H]) (CC[C@@] (O7) (CC (=O) C[C@]8 ([C@@] (O[C@H] (C[C@@H] (CNC (OCC9=CC=C (NC ([C@@H] (NC ([C@@H] (NC (CCOCCOCCOCCOCCOCCOCCNC (OCC%10C=%11C (C=%12C%10=CC=CC%12) =CC=CC%11) =O) =O) [C@@H] (C) C) =O) CCCNC (N) =O) =O) C=C9) =O) O) [C@@H]8OC) (C[C@]%13 (O[C@@] (CC[C@@]1 (O2) [H]) (C[C@@H] (C) C%13=C) [H]) [H]) [H]) [H]) [H]) [H]) [H]) [H]) [H]) [H]) [H]) [H]
Molecular Formula
C89H125N7O25
Molecular Weight
1693
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881429-100 1x 100 µL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC402906 20 µg
CIDE C (CIDEC) (NM_022094) Human Over-expression Lysate
Sign In for Pricing
View Details 
